Cargando…
Association of hepcidin‐25 with survival after kidney transplantation
BACKGROUND: Hepcidin is considered the master regulator of iron homoeostasis. Novel hepcidin antagonists have recently been introduced as potential treatment for iron‐restricted anaemia. Meanwhile, serum hepcidin has been shown to be positively associated with cardiovascular disease and inversely wi...
Autores principales: | Eisenga, Michele F., Dullaart, Robin P. F., Berger, Stefan P., Sloan, John H., de Vries, Aiko P. J., Bakker, Stephan J. L., Gaillard, Carlo A. J. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5132077/ https://www.ncbi.nlm.nih.gov/pubmed/27696386 http://dx.doi.org/10.1111/eci.12682 |
Ejemplares similares
-
Urinary prednisolone excretion is a determinant of serum hepcidin levels in renal transplant recipients
por: Eisenga, Michele F., et al.
Publicado: (2017) -
Iron Deficiency Defined by Hepcidin in Critically Ill Patients
por: Eisenga, Michele F.
Publicado: (2021) -
Iron deficiency, with and without anaemia, across strata of kidney function in kidney transplant recipients
por: Ayerdem, Gizem, et al.
Publicado: (2021) -
Erythropoietin, Fibroblast Growth Factor 23, and Death After Kidney Transplantation
por: Eisenga, Michele F., et al.
Publicado: (2020) -
Association of different iron deficiency cutoffs with adverse outcomes in chronic kidney disease
por: Eisenga, Michele F., et al.
Publicado: (2018)